$DERM
Journey Medical Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$4.44
▲+3.26%+$0.140Market open
Journey Medical Corporation Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is DERM up today? It is at $4.44 (+3.26%), and our scanner flagged it 39 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DERM spikes, and full due diligence on DERM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $DERM 39 times in the last 30 days. Create a free account to track $DERM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on DERM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DERM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystJourney Medical Corp: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedOct 9, 2026 · 27 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Herskowitz Neil Director | Acquired (grant/award) | +50K 0.4% of company | added 42% | 169K | n/a | Jul 1, 26 |
Smith Justin Adam Director | Acquired (grant/award) | +50K 0.4% of company | added 28% | 232K | n/a | Jul 1, 26 |
Toledano Miranda Jayne Director | Acquired (grant/award) | +50K 0.4% of company | added 42% | 169K | n/a | Jul 1, 26 |
Rosenwald Lindsay A Md Director | Acquired (grant/award) | +10K 0.09% of company | added 4.7% | 221K | n/a | Jun 25, 26 |
Pearce Michael Cooper Director | Acquired (grant/award) | +10K 0.09% of company | added 17% | 67K | n/a | Jun 25, 26 |
Herskowitz Neil Director | Acquired (grant/award) | +10K 0.09% of company | added 9.2% | 119K | n/a | Jun 25, 26 |
Smith Justin Adam Director | Acquired (grant/award) | +10K 0.09% of company | added 5.8% | 182K | n/a | Jun 25, 26 |
Toledano Miranda Jayne Director | Acquired (grant/award) | +10K 0.09% of company | added 9.2% | 119K | n/a | Jun 25, 26 |
Maraoui Claude Officer | Acquired (grant/award) | +49K 0.4% of company | added 2.1% | 2.44M | n/a | Apr 22, 26 |
Benesch Joseph Officer | Acquired (grant/award) | +29K 0.3% of company | added 12% | 261K | n/a | Apr 22, 26 |
Alloush Ramsey Officer | Acquired (grant/award) | +47K 0.4% of company | added 8.5% | 599K | n/a | Apr 22, 26 |
Maraoui Claude Officer | Sold (automatic/other) | -11K 0.09% of company | sold 0.5% | 2.39M | $81K at $7.47 | Aug 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on DERM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DERM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
DERM last traded at $4.44, up 3.26% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Journey Medical Corporation Common Stock (DERM) is next expected to report earnings on Wednesday, November 11, 2026, about 5 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The DERM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DERM 39 times in the last 30 days.
DERM (Journey Medical Corporation Common Stock) trades on XNAS, with a market cap of about $50M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DERM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$DERM discussion
Sign in to ask a question or join the discussion.